GENEVA, May 14 -- MYRIAD WOMEN'S HEALTH, INC. (180 Kimball WaySouth San Francisco, California 94080) filed a patent application (PCT/US2024/053386) for "IMPROVED SENSITIVITY OF TUMOR-INFORMED MINIMAL RESIDUAL DISEASE PANELS" on Oct 29, 2024. With publication no. WO/2025/096423, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ACEVEDO, Ashley (c/o Myriad Women's Health, Inc.180 Kimball WaySouth San Francisco, California 94080)

Abstract: Described herein are methods for improving sensitivity of tumor-informed MRD assays a...